A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

DOV Pharmaceuticals

About DOV

DOV Pharmaceuticals is a biopharmaceutical company focused on the discovery, in-licensing, development and commercialization of novel drug candidates for central nervous system, and other disorders, including cardiovascular, that involve alterations in neural processing.

DOV has six product candidates in clinical trials targeting insomnia, anxiety disorders, pain, depression and angina and hypertension. The Company has established strategic alliances with select partners in part to access their unique technologies and commercialization capabilities. The Company operates principally in the United States but also conducts clinical studies in Canada and Europe. In 1998, DOV licensed four of their product candidates from Wyeth:

indiplon, for the treatment of insomnia,

bicifadine, for the treatment of pain,

ocinaplon, for the treatment of generalized anxiety disorder,

DOV 216,303, and DOV 21,947 for the treatment of depression, anxiety and substance abuse .

DOV Diltiazen for Angina and Hypertension


Product Pipeline DOV Pharmaceuticals


More on DOV Pharmaceuticals

Home Page

Key Statistics for DOV Pharmaceuticals

Basic Chart for DOV Pharmaceuticals

Analyst Opinion

Analysts Estimates


Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright 2005 BIOTECH100.COM. All rights reserved.